TrialBMJ open diabetes research & care2020

Efficacy and safety of insulin glargine 300 U/mL (Gla-300) during hospitalization and therapy intensification at discharge in patients with insufficiently controlled type 2 diabetes: results of the phase IV COBALTA trial.

Antonio Perez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.